Surgical management of ovarian cancer

被引:35
作者
Mutch, DG [1 ]
机构
[1] Washington Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, St Louis, MO 63110 USA
关键词
D O I
10.1053/sonc.2002.31589
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The management of ovarian cancer presents one of the greatest challenges to physicians caring for patients with cancer. The treatment almost always involves a combination of surgery and chemotherapy. Over the past 75 years we have formed a rational system for the surgical management of this disease. Initial surgical therapy should include the following three objectives: (1) staging, (2) cytoreduction, and (3) determining a definitive histologic diagnosis. The importance of meticulous staging cannot be overstated. Fully one third of patients not compulsively staged will be upstaged if surgically restaged. Cytoreductive surgery is the mainstay of initial treatment. Data clearly demonstrate that ovarian cancer is different from other solid tumors in that reduction of the tumor burden is important in the management of this disease. Patients with less than 1 to 2 cm of disease remaining at the conclusion of initial surgery have a survival advantage over those who do not. The benefits of secondary cytoreduction are less clear, and data support the concept of cytoreduction in many circumstances. These surgical issues surrounding ovarian cancer support the concept that physicians trained to treat ovarian cancer be involved in its management. Data are emerging that clearly suggest that gynecologic oncologists should be involved in both the surgical and medical management of patients with ovarian cancer. Copyright © 2002 by W.B. Saunders Company.
引用
收藏
页码:3 / 8
页数:6
相关论文
共 37 条
[31]   10-YEAR FOLLOW-UP OF PATIENTS RECEIVING CISPLATIN, DOXORUBICIN, AND CYCLOPHOSPHAMIDE CHEMOTHERAPY FOR ADVANCED EPITHELIAL OVARIAN-CARCINOMA [J].
SUTTON, GP ;
STEHMAN, FB ;
EINHORN, LH ;
ROTH, LM ;
BLESSING, JA ;
EHRLICH, CE .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (02) :223-229
[32]   THE EFFECT OF DEBULKING SURGERY AFTER INDUCTION CHEMOTHERAPY ON THE PROGNOSIS IN ADVANCED EPITHELIAL OVARIAN-CANCER [J].
VANDERBURG, MEL ;
VANLENT, M ;
BUYSE, M ;
KOBIERSKA, A ;
COLOMBO, N ;
FAVALLI, G ;
LACAVE, AJ ;
NARDI, M ;
RENARD, J ;
PECORELLI, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (10) :629-634
[33]  
VOGL SE, 1983, CANCER, V51, P2024, DOI 10.1002/1097-0142(19830601)51:11<2024::AID-CNCR2820511111>3.0.CO
[34]  
2-I
[35]  
WHARTON JT, 1983, CLIN OBSTET GYNAECOL, V10, P235
[36]  
YOUNES RN, 1994, SHOCK S, V1, P2
[37]   STAGING LAPAROTOMY IN EARLY OVARIAN-CANCER [J].
YOUNG, RC ;
DECKER, DG ;
WHARTON, JT ;
PIVER, MS ;
SINDELAR, WF ;
EDWARDS, BK ;
SMITH, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 250 (22) :3072-3076